Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$63.15 - $90.42 $259,799 - $371,987
-4,114 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$77.28 - $99.42 $132,457 - $170,405
1,714 Added 71.42%
4,114 $370,000
Q3 2021

Nov 10, 2021

SELL
$65.97 - $92.48 $8,048 - $11,282
-122 Reduced 4.84%
2,400 $222,000
Q2 2021

Aug 10, 2021

BUY
$69.38 - $86.75 $171,368 - $214,272
2,470 Added 4750.0%
2,522 $196,000
Q1 2021

May 14, 2021

SELL
$72.25 - $168.95 $223,252 - $522,055
-3,090 Reduced 98.35%
52 $4,000
Q4 2020

Feb 08, 2021

BUY
$125.56 - $178.74 $394,509 - $561,601
3,142 New
3,142 $536,000
Q4 2019

Feb 12, 2020

SELL
$76.53 - $135.58 $3.83 Million - $6.78 Million
-50,000 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$72.81 - $156.91 $3.64 Million - $7.85 Million
50,000 New
50,000 $3.77 Million
Q1 2019

May 10, 2019

SELL
$106.67 - $151.68 $8.56 Million - $12.2 Million
-80,211 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$97.32 - $148.76 $7.81 Million - $11.9 Million
80,211 New
80,211 $8.75 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Agf Investments Inc. Portfolio

Follow Agf Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.